Embecta (NASDAQ: EMBC) insider transactions
In the twelve months to 10 November 2026, executives and directors of Embecta reported 1 open-market sale of 6,293 shares ($37,003) and 4 open-market purchases of 115,000 shares ($557,850), by 5 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 4 September 2026 | Morris Milton Mayo | Director | Open-market sale | −6,293 | $5.88 | 53,828 | Form 4 |
| 12 August 2026 | Hombach Robert J. | Director | Open-market purchase | +45,000 | $4.97 | 109,587 | Form 4 |
| 12 August 2026 | Mann Jeffrey Z | Pres, Pharm Svc&Prod Mgmt, CLO | Open-market purchase | +20,000 | $4.99 | 262,915 | Form 4 |
| 12 August 2026 | Elguicze Jacob | SVP and CFO | Open-market purchase | +20,000 | $4.67 | 309,139 | Form 4 |
| 12 August 2026 | Kurdikar Devdatt | President and CEO | Open-market purchase | +30,000 | $4.70 | 804,919 | Form 4 |
| 9 August 2026 | Casner Jean | Chief Human Resources Officer | Shares withheld for tax | −1,480 | $4.42 | 85,915 | Form 4 |
| 1 June 2026 | Roth Anthony M. | VP, Chief Accounting Officer | Grant or award | +30,000 | — | 78,833 | Form 4 |
| 11 February 2026 | Reidy Christopher R | Director | Grant or award | +22,841 | — | 70,122 | Form 4 |
| 11 February 2026 | Pomeroy Claire | Director | Grant or award | +22,841 | — | 66,127 | Form 4 |
| 11 February 2026 | Prange Karen | Director | Grant or award | +22,841 | — | 64,581 | Form 4 |
| 11 February 2026 | Morris Milton Mayo | Director | Grant or award | +22,841 | — | 60,121 | Form 4 |
| 11 February 2026 | Hombach Robert J. | Director | Grant or award | +22,841 | — | 64,587 | Form 4 |
| 11 February 2026 | Anderson Carrie L | Director | Grant or award | +22,841 | — | 64,581 | Form 4 |
| 26 November 2025 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Grant or award | +37,789 | — | 99,399 | Form 4 |
| 26 November 2025 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Grant or award | +11,305 | — | 110,704 | Form 4 |
| 26 November 2025 | Curtis Shaun | SVP, Global Manuf./Sup. Chain | Shares withheld for tax | −15,380 | $12.57 | 95,324 | Form 4 |
| 26 November 2025 | Elguicze Jacob | SVP and CFO | Grant or award | +95,466 | — | 267,863 | Form 4 |
| 26 November 2025 | Elguicze Jacob | SVP and CFO | Grant or award | +30,147 | — | 298,010 | Form 4 |
| 26 November 2025 | Elguicze Jacob | SVP and CFO | Shares withheld for tax | −24,782 | $12.57 | 273,228 | Form 4 |
| 26 November 2025 | Kurdikar Devdatt | President and CEO | Grant or award | +288,386 | — | 799,923 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Embecta page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.